XIAP and acute lymphoblastic leukemia: In contrast, KD of XIAP phenocopies the effect of SM treatment in sensitizing r/r ALL cells towards chemotherapy, suggesting that the caspase‐inhibitor XIAP might be the direct target of SM in r/r ALL.